GC
RCEL icon

Globeflex Capital’s Avita Medical RCEL Stock Holding History

Globeflex Capital’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-76,856
Closed -$1.23M – 518
2024
Q1 		$1.23M Hold
76,856
– – 0.12% 167
2023
Q4 		$1.05M Hold
76,856
– – 0.11% 179
2023
Q3 		$1.12M Sell
76,856
-37,361
-33% -$632K 0.13% 160
2023
Q2 		$1.94M Sell
114,217
-4,645
-4% -$68.2K 0.22% 119
2023
Q1 		$1.66M Buy
118,862
+76,856
+183% +$818K 0.2% 124
2022
Q4 		$277K Buy
+42,006
New +$252K 0.04% 322

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Globeflex Capital's RCEL Position: Q2 2024 in Review

Globeflex Capital sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 76,856 shares — an estimated $1.23M sold.

Globeflex Capital first reported a position in RCEL in Q4 2022 and held it in 6 quarters. The position peaked at $1.94M in Q2 2023. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • Globeflex Capital reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • Globeflex Capital sold 76,856 Avita Medical shares in Q2 2024, an estimated $1.23M.
  • Globeflex Capital first reported a position in Avita Medical in Q4 2022 and held it in 6 quarters.
  • Globeflex Capital's Avita Medical position peaked at $1.94M in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Globeflex Capital's 13F filing for Q2 2024, filed 13 Aug 2024.